CA
AMPH icon

Clearstead Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Clearstead Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344 Buy
+17
New +$343 ﹤0.01% 3037
2025
Q1 		– Sell
-108
Closed -$4.01K – 2200
2024
Q4 		$4.01K Hold
108
– – ﹤0.01% 1754
2024
Q3 		$5.24K Hold
108
– – ﹤0.01% 1704
2024
Q2 		$4.32K Buy
108
+8
+8% +$332 ﹤0.01% 1707
2024
Q1 		$4.24K Sell
100
-19
-16% -$981 ﹤0.01% 1199
2023
Q4 		$7.36K Buy
119
+92
+341% +$4.83K ﹤0.01% 1108
2023
Q3 		$1.24K Hold
27
– – ﹤0.01% 1327
2023
Q2 		$1.55K Sell
27
-78
-74% -$3.46K ﹤0.01% 1197
2023
Q1 		$3.94K Hold
105
– – ﹤0.01% 1046
2022
Q4 		$2.94K Buy
+105
New +$3.05K ﹤0.01% 1047

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Clearstead Advisors's AMPH Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 17 shares worth $344. The stake represents ﹤0.01% of the portfolio and ranks #3037 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in AMPH as recently as Q4 2024.

Clearstead Advisors first reported a position in AMPH in Q4 2022 and has held it in 10 quarters since. The position peaked at $7.36K in Q4 2023. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Clearstead Advisors held 17 shares of Amphastar Pharmaceuticals worth $344 as of Q2 2026.
  • Amphastar Pharmaceuticals was a new Clearstead Advisors position in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3037 holding.
  • Clearstead Advisors first reported a position in Amphastar Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
  • Clearstead Advisors's Amphastar Pharmaceuticals position peaked at $7.36K in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.